BGU researchers are on the verge of a breakthrough that is bringing the world closer to a cure for diabetes.
Researchers at BGU’s Clinical Islet Laboratory are pursuing three major goals: transplants and new drugs, gene therapy, and the creation of a “transgenic” mouse that can tolerate human material for experimentation. They’re working on new drugs based on the alpha-1-antitrypsin (AAT) protein that reduces inflammation. Recent clinical trials demonstrated that infusion of AAT in recently diagnosed type 1 diabetes patients could eventually eliminate the need for insulin injections. A new clinical trial is under way to evaluate AAT dosing levels and duration.
Diabetes Videossee all videos
Diabetes Newssee all news
Wine Tied to Healthier Arteries for Some Diabetics
BGU studied people with type 2 diabetes who drank wine daily as part of a Mediterranean diet.
“Super Enzyme” Improves Glucose Level Testing
BGU researchers engineer a new method that measures blood-sugar levels faster and more accurately.
Reversing Type 1 Diabetes
Using the alpha-1 protein, Prof. Eli Lewis has eliminated some patients’ need for insulin injections.